Monoclonal antibodies, intelligent molecules capable of cleansing the brain of Beta-Amyloid accumulation, experimental drugs developed in overseas laboratories, transcranial magnetic stimulation, cognitive training supported by virtual reality: all are part of treatment plans for Alzheimer’s patients today.

Full Story